2007³â Á¦13Â÷ ¼¿ï´ëÇб³º´¿ø Ç÷¾×Á¾¾ç ¿¬¼ö°ÁÂ
- ÀÛ¼ºÀÚ
- °ü¸®ÀÚ
- ÷ºÎÆÄÀÏ
- Á¦13Â÷¼¿ï´ëÇб³º´¿øÇ÷¾×Á¾¾ç¿¬¼ö°ÁÂ.doc (Down : 771)
- ÀÛ¼ºÀÏ
- 2007-03-05
- Á¶È¸
- 7507
2007³â Á¦13Â÷ ¼¿ï´ëÇб³º´¿ø Ç÷¾×Á¾¾ç ¿¬¼ö°ÁÂ
¡Þ¸ð½Ã´Â ±Û¡Þ
Ç÷¾×Á¾¾çÇÐ ¿¬¼ö°Á¿¡ ÁîÀ½ÇÏ¿©
±Þº¯ÇÏ°í ÀÖ´Â Çö´ë ÀÇÇп¡ ´ëóÇÏ°í ÀÇ·á¼öÁØÀÇ Áö¼ÓÀûÀÎ Çâ»óÀ» À§ÇÏ¿© ÀÇ·áÀο¡ ´ëÇÑ Æò»ý±³À°ÀÇ Á߿伺Àº ¿ì¸® ¸ðµÎ°¡ ÁÖÁöÇÏ°í ÀÖ´Â »ç½ÇÀÔ´Ï´Ù. ÀÌ·± ¸ñÀûÀ» ´Þ¼ºÇϱâ À§ÇÏ¿© ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¹× º´¿ø¿¡¼´Â Çظ¶´Ù °¢ ºÐ¾ßº°·Î ¿¬¼ö°Á¸¦ °³ÃÖÇØ ¿À°í ÀÖ½À´Ï´Ù.
À̹ø 2007³âµµ Á¦13Â÷ Ç÷¾×Á¾¾çÇÐ ¿¬¼ö°Á¿¡¼´Â "Hematology 2007: State-of-the-Art Review " ¶ó´Â ÁÖÁ¦·Î ±Þ¼ÓÇÑ ¼Óµµ·Î ¹ßÀüÇÏ°í ÀÖ´Â Ç÷¾×Á¾¾çÇÐ ºÐ¾ß¿¡ ´ëÇÑ ÃֽŠÁö°ßÀ» ³íÀÇÇÏ°íÀÚ ÇÕ´Ï´Ù. º» °Á´ Ç÷¾×Á¾¾çÇп¡ °ü½ÉÀ» °¡Áø ¸ðµç ºÐµé²² Å« µµ¿òÀÌ µÉ °ÍÀ¸·Î È®½ÅÇÏ´Â ¹ÙÀ̸ç, ¸¹Àº Âü¿©¿Í È°¹ßÇÑ ÅäÀǸ¦ ±â´ëÇÕ´Ï´Ù.
2007³â 2¿ù
¼¿ï´ëÇб³º´¿ø ³»°ú°úÀå ¹Ú ¿µ ¹è
Ç÷¾×Á¾¾çºÐ°úÀå ¹æ ¿µ ÁÖ
-Á¦¸ñ: Hematology 2007: State-of-the-Art Review
-ÀϽÃ: 2007³â 4¿ù 6ÀÏ(±Ý) 11:30 – 18:50
-Àå¼Ò: ¼¿ï´ëÇб³ ¾Ï¿¬±¸¼Ò »ï¼º¾Ï¿¬±¸µ¿ ´ë°´ç
-´ë»ó: Ç÷¾×Á¾¾çÇÐ °ü·Ã ³»°ú, ¼Ò¾Æ°ú, Áø´Ü°Ë»çÀÇÇаú Àü¹®ÀÇ, °³¿øÀÇ, ÀüÀÓÀÇ, Àü°øÀÇ, °£È£»ç
-¿¬¼öÆòÁ¡:
´ëÇÑÀÇ»çÇùȸ 4ÆòÁ¡
´ëÇѳ»°úÇÐȸ Ç÷¾×Á¾¾ç³»°ú ºÐ°úÀü¹®ÀÇ 5ÆòÁ¡
-¹®ÀÇ»çÇ× ¾È³» ¹× ¿¬¶ôó:
110-744 ¼¿ï½Ã Á¾·Î±¸ ¿¬°Çµ¿ 28 ¼¿ï´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°ú
ÀüÈ: 02-2072-3981 Fax: 02-3673-2227, E-mail: hmo_snuh@yahoo.co.kr
-¼ö°·á: (±³ÀçÁ¦°ø)
»çÀüµî·Ï : 3¸¸¿ø (ÀüÀÓÀÇ/Àü°øÀÇ/°£È£»ç : 2¸¸¿ø)
ÇöÀåµî·Ï : 4¸¸¿ø (ÀüÀÓÀÇ/Àü°øÀÇ/°£È£»ç : 3¸¸¿ø)
*»çÀü µî·Ï ¸¶°¨Àº 3¿ù 25ÀÏÀ̸ç FAX 02-3673-2227 ¶Ç´Â ¼¿ï´ëº´¿ø Ç÷¾×Á¾¾ç³»°ú ȨÆäÀÌÁö(http://hmo.snuh.org)¸¦ ÅëÇÏ¿© µî·ÏÀÌ °¡´ÉÇÕ´Ï´Ù.
*»çÀü µî·Ï½Ã ½ÅûÀÎÀÇ ¼º¸íÀ» ÇÊÈ÷ ±âÀÔÇϽðí, ¾Æ·¡ÀÇ ÀºÇà°èÁ·ΠÀԱݽÃÄÑ ÁֽʽÿÀ. Âü°¡ºñ´Â »çÀüµî·Ï 3¸¸¿ø, ÇöÀåµî·Ï 4¸¸¿øÀÔ´Ï´Ù.
(ÀüÀÓÀÇ, Àü°øÀÇ´Â 2¸¸¿ø / 3¸¸¿ø)
*¿¹±ÝÁÖ: ¹æ¿µÁÖ, ½ÅÇÑÀºÇà: ¿¬°Çµ¿ÁöÁ¡, °èÁ¹øÈ£: 367-04-934598
- ÀÏÁ¤Ç¥
12:00 registration
12:55 - 1:00 opening remark
1ºÎ ÁÂÀå: ¹Ú¼±¾ç (¼¿ïÀÇ´ë)
1:00 - 1:20 Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia : À̱ÔÇü (¼¿ï¾Æ»êº´¿ø)
1:20 - 1:40 Treatment of Acute Promyelocytic Leukemia : Çö¸í¼ö (¿µ³²ÀÇ´ë)
1:40 - 2:00 Updates in the Management of Patients with MDS : ±èÇüÁØ (Àü³²ÀÇ´ë)
2:00 - 2:20 Discussion
2ºÎ ÁÂÀå: ȲÅÂÁÖ (Àü³²ÀÇ´ë)
2:20 - 2:40 Defining and Managing Imatinib Resistance in CML: ¹Ú¼±¾ç (¼¿ïÀÇ´ë)
2:40 - 3:00 New Strategies for the Treatment of AML Including Antibodies and Other Novel Agents : ¹ÎÀ¯È« (¿¬¼¼ÀÇ´ë)
3:00 - 3:20 The Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukemia : ÁÖ¿µµ· (ÀÎÁ¦ÀÇ´ë)
3:20 - 3:40 Discussion
3:40 - 4:00 ÈÞ½Ä
3ºÎ ÁÂÀå: ±èö¼ö (ÀÎÇÏÀÇ´ë)
4:00 - 4:20 Therapies for Relapsed Hodgkin Lymphoma: ÀÌÁ¾¼® (¼¿ïÀÇ´ë)
4:20 - 4:40 Non-Hodgkin Lymphoma: Risk Stratification and Management of Relapsed Disease : ±èö¼ö (ÀÎÇÏÀÇ´ë)
4:40 - 5:00 An Update of the Management of Multiple Myeloma : À±¼º¼ö (¼¿ïÀÇ´ë)
5:00 - 5:20 Discussion
4ºÎ ÁÂÀå: ±èº´±¹ (¼¿ïÀÇ´ë)
5:20 - 5:40 Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation : ±èÀÎÈ£ (¼¿ïÀÇ´ë)
5:40 - 6:00 Umbilical Cord Blood Transplantation : ±¸È«È¸ (¼º±Õ°üÀÇ´ë)
6:00 - 6:20 Haploidentical Stem Cell Transplantation : ±èÈñÁ¦ (°¡Å縯ÀÇ´ë)
6:20 - 6:40 Discussion
6:40 - 6:50 Closing remark : ±èº´±¹ (¼¿ïÀÇ´ë)
¡Þ¸ð½Ã´Â ±Û¡Þ
Ç÷¾×Á¾¾çÇÐ ¿¬¼ö°Á¿¡ ÁîÀ½ÇÏ¿©
±Þº¯ÇÏ°í ÀÖ´Â Çö´ë ÀÇÇп¡ ´ëóÇÏ°í ÀÇ·á¼öÁØÀÇ Áö¼ÓÀûÀÎ Çâ»óÀ» À§ÇÏ¿© ÀÇ·áÀο¡ ´ëÇÑ Æò»ý±³À°ÀÇ Á߿伺Àº ¿ì¸® ¸ðµÎ°¡ ÁÖÁöÇÏ°í ÀÖ´Â »ç½ÇÀÔ´Ï´Ù. ÀÌ·± ¸ñÀûÀ» ´Þ¼ºÇϱâ À§ÇÏ¿© ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¹× º´¿ø¿¡¼´Â Çظ¶´Ù °¢ ºÐ¾ßº°·Î ¿¬¼ö°Á¸¦ °³ÃÖÇØ ¿À°í ÀÖ½À´Ï´Ù.
À̹ø 2007³âµµ Á¦13Â÷ Ç÷¾×Á¾¾çÇÐ ¿¬¼ö°Á¿¡¼´Â "Hematology 2007: State-of-the-Art Review " ¶ó´Â ÁÖÁ¦·Î ±Þ¼ÓÇÑ ¼Óµµ·Î ¹ßÀüÇÏ°í ÀÖ´Â Ç÷¾×Á¾¾çÇÐ ºÐ¾ß¿¡ ´ëÇÑ ÃֽŠÁö°ßÀ» ³íÀÇÇÏ°íÀÚ ÇÕ´Ï´Ù. º» °Á´ Ç÷¾×Á¾¾çÇп¡ °ü½ÉÀ» °¡Áø ¸ðµç ºÐµé²² Å« µµ¿òÀÌ µÉ °ÍÀ¸·Î È®½ÅÇÏ´Â ¹ÙÀ̸ç, ¸¹Àº Âü¿©¿Í È°¹ßÇÑ ÅäÀǸ¦ ±â´ëÇÕ´Ï´Ù.
2007³â 2¿ù
¼¿ï´ëÇб³º´¿ø ³»°ú°úÀå ¹Ú ¿µ ¹è
Ç÷¾×Á¾¾çºÐ°úÀå ¹æ ¿µ ÁÖ
-Á¦¸ñ: Hematology 2007: State-of-the-Art Review
-ÀϽÃ: 2007³â 4¿ù 6ÀÏ(±Ý) 11:30 – 18:50
-Àå¼Ò: ¼¿ï´ëÇб³ ¾Ï¿¬±¸¼Ò »ï¼º¾Ï¿¬±¸µ¿ ´ë°´ç
-´ë»ó: Ç÷¾×Á¾¾çÇÐ °ü·Ã ³»°ú, ¼Ò¾Æ°ú, Áø´Ü°Ë»çÀÇÇаú Àü¹®ÀÇ, °³¿øÀÇ, ÀüÀÓÀÇ, Àü°øÀÇ, °£È£»ç
-¿¬¼öÆòÁ¡:
´ëÇÑÀÇ»çÇùȸ 4ÆòÁ¡
´ëÇѳ»°úÇÐȸ Ç÷¾×Á¾¾ç³»°ú ºÐ°úÀü¹®ÀÇ 5ÆòÁ¡
-¹®ÀÇ»çÇ× ¾È³» ¹× ¿¬¶ôó:
110-744 ¼¿ï½Ã Á¾·Î±¸ ¿¬°Çµ¿ 28 ¼¿ï´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°ú
ÀüÈ: 02-2072-3981 Fax: 02-3673-2227, E-mail: hmo_snuh@yahoo.co.kr
-¼ö°·á: (±³ÀçÁ¦°ø)
»çÀüµî·Ï : 3¸¸¿ø (ÀüÀÓÀÇ/Àü°øÀÇ/°£È£»ç : 2¸¸¿ø)
ÇöÀåµî·Ï : 4¸¸¿ø (ÀüÀÓÀÇ/Àü°øÀÇ/°£È£»ç : 3¸¸¿ø)
*»çÀü µî·Ï ¸¶°¨Àº 3¿ù 25ÀÏÀ̸ç FAX 02-3673-2227 ¶Ç´Â ¼¿ï´ëº´¿ø Ç÷¾×Á¾¾ç³»°ú ȨÆäÀÌÁö(http://hmo.snuh.org)¸¦ ÅëÇÏ¿© µî·ÏÀÌ °¡´ÉÇÕ´Ï´Ù.
*»çÀü µî·Ï½Ã ½ÅûÀÎÀÇ ¼º¸íÀ» ÇÊÈ÷ ±âÀÔÇϽðí, ¾Æ·¡ÀÇ ÀºÇà°èÁ·ΠÀԱݽÃÄÑ ÁֽʽÿÀ. Âü°¡ºñ´Â »çÀüµî·Ï 3¸¸¿ø, ÇöÀåµî·Ï 4¸¸¿øÀÔ´Ï´Ù.
(ÀüÀÓÀÇ, Àü°øÀÇ´Â 2¸¸¿ø / 3¸¸¿ø)
*¿¹±ÝÁÖ: ¹æ¿µÁÖ, ½ÅÇÑÀºÇà: ¿¬°Çµ¿ÁöÁ¡, °èÁ¹øÈ£: 367-04-934598
- ÀÏÁ¤Ç¥
12:00 registration
12:55 - 1:00 opening remark
1ºÎ ÁÂÀå: ¹Ú¼±¾ç (¼¿ïÀÇ´ë)
1:00 - 1:20 Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia : À̱ÔÇü (¼¿ï¾Æ»êº´¿ø)
1:20 - 1:40 Treatment of Acute Promyelocytic Leukemia : Çö¸í¼ö (¿µ³²ÀÇ´ë)
1:40 - 2:00 Updates in the Management of Patients with MDS : ±èÇüÁØ (Àü³²ÀÇ´ë)
2:00 - 2:20 Discussion
2ºÎ ÁÂÀå: ȲÅÂÁÖ (Àü³²ÀÇ´ë)
2:20 - 2:40 Defining and Managing Imatinib Resistance in CML: ¹Ú¼±¾ç (¼¿ïÀÇ´ë)
2:40 - 3:00 New Strategies for the Treatment of AML Including Antibodies and Other Novel Agents : ¹ÎÀ¯È« (¿¬¼¼ÀÇ´ë)
3:00 - 3:20 The Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukemia : ÁÖ¿µµ· (ÀÎÁ¦ÀÇ´ë)
3:20 - 3:40 Discussion
3:40 - 4:00 ÈÞ½Ä
3ºÎ ÁÂÀå: ±èö¼ö (ÀÎÇÏÀÇ´ë)
4:00 - 4:20 Therapies for Relapsed Hodgkin Lymphoma: ÀÌÁ¾¼® (¼¿ïÀÇ´ë)
4:20 - 4:40 Non-Hodgkin Lymphoma: Risk Stratification and Management of Relapsed Disease : ±èö¼ö (ÀÎÇÏÀÇ´ë)
4:40 - 5:00 An Update of the Management of Multiple Myeloma : À±¼º¼ö (¼¿ïÀÇ´ë)
5:00 - 5:20 Discussion
4ºÎ ÁÂÀå: ±èº´±¹ (¼¿ïÀÇ´ë)
5:20 - 5:40 Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation : ±èÀÎÈ£ (¼¿ïÀÇ´ë)
5:40 - 6:00 Umbilical Cord Blood Transplantation : ±¸È«È¸ (¼º±Õ°üÀÇ´ë)
6:00 - 6:20 Haploidentical Stem Cell Transplantation : ±èÈñÁ¦ (°¡Å縯ÀÇ´ë)
6:20 - 6:40 Discussion
6:40 - 6:50 Closing remark : ±èº´±¹ (¼¿ïÀÇ´ë)